VYXEOS can be administered in an outpatient setting for appropriate patients1,2
Patient factors to consider for outpatient administration with VYXEOS
Deemed stable by
medical team3-6
- ECOG PS 0-1 and no significant comorbidities such as kidney or cardiopulmonary diseases or active uncontrolled infections
Capable of self-care activities3,5
- Ability to consistently attend all scheduled visits and participate in self-care activities such as taking temperature
In close proximity to their infusion center3,5
- Ability to consistently attend all scheduled visits for treatment and monitoring
Institutional factors to consider for outpatient administration with VYXEOS
Timely access to supportive care that may include3,5
- Blood and platelet transfusion support
- Prophylactic antimicrobial implementation
A multidisciplinary team that can3,5
- Coordinate and manage expectations for outpatient care with the patient
- Assess and evaluate lab results
- Monitor symptoms, side effects, and/or signs of toxicity
Inpatient access that allows for3
- Unplanned admission due to urgent adverse events
“Successful implementation of an outpatient approach requires that patients have quick, easy access to providers.”5
– Treating hematologist
Learn more about induction, consolidation, and outpatient administration with VYXEOS
Download PDFExplore an expansive video library, where experts discuss outpatient use of VYXEOS
Watch videos